CAPTRUST FINANCIAL ADVISORS - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 152 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$41,000
-32.8%
870
+2.1%
0.00%
Q1 2022$61,000
+335.7%
852
+343.8%
0.00%
Q4 2021$14,000
+40.0%
192
+5.5%
0.00%
Q3 2021$10,000
+25.0%
182
-0.5%
0.00%
Q2 2021$8,000
-27.3%
183
-20.8%
0.00%
Q1 2021$11,000
+450.0%
231
+477.5%
0.00%
Q4 2020$2,000
+100.0%
40
+100.0%
0.00%
Q3 2020$1,000200.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 862,848$42,556,00014.73%
Fairmount Funds Management LLC 171,147$8,441,0003.56%
ARMISTICE CAPITAL, LLC 1,648,000$81,279,0001.87%
FARALLON CAPITAL MANAGEMENT LLC 1,995,000$98,393,0000.49%
Jackson Creek Investment Advisors LLC 21,409$1,056,0000.37%
Hennion & Walsh Asset Management, Inc. 113,940$5,620,0000.34%
Virtus ETF Advisers LLC 14,721$726,0000.31%
Granahan Investment Management 193,416$9,539,0000.20%
Yorktown Management & Research Co Inc 4,500$222,0000.18%
JACOBS LEVY EQUITY MANAGEMENT, INC 242,257$11,948,0000.09%
View complete list of ENANTA PHARMACEUTICALS INC shareholders